Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_assertion type Assertion NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_head.
- NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_assertion description "[Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_provenance.
- NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_assertion evidence source_evidence_literature NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_provenance.
- NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_assertion SIO_000772 9192768 NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_provenance.
- NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_assertion wasDerivedFrom befree-20150227 NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_provenance.
- NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_assertion wasGeneratedBy ECO_0000203 NP847927.RAP5uaRNUKsDpgNFnkDY-slMPZW4SVDEoxt5Y5W4QzAR8130_provenance.